Fluenz [Influenza Vaccine (Live attenuated, nasal)] clinical trials

A clinical trial of the safety of the live, attenuated influenza vaccine nasal spray in children aged 12 - 23 months

This study looks at a nasal flu vaccine for children aged 12 to 23 months. Flu can be serious for young children. We want to see if the nasal spray is safe for this age group, especially regarding breathing problems. Every child gets both the vaccine and a dummy spray.